Results
92
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
92 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.22 | -8.4% | -3.5% | SEK 330.3m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech | ||
YUBICO | SEK 257.50 | -7.2% | 156.0% | SEK 22.2b | SEK 296.67 | PE114.4x | E42.5% | n/a | Software | ||
MAGLE | SEK 37.60 | -2.6% | 20.5% | SEK 406.1m | SEK 50.00 | PE52.8x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 274.00 | -1.8% | 19.7% | SEK 3.4b | n/a | PE33.7x | E24.8% | 2.0% | Capital Goods | ||
TRUE B | SEK 36.00 | 5.3% | -2.1% | SEK 12.4b | SEK 57.20 | PE26x | E21.6% | 1.1% | Software | ||
FNOX | SEK 59.94 | 3.9% | 9.4% | SEK 36.6b | SEK 77.88 | PE56.2x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 174.80 | 6.5% | -43.0% | SEK 15.4b | SEK 290.60 | PS51.6x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.65 | 1.3% | -64.3% | SEK 222.8m | SEK 7.90 | PS30.5x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.38 | 7.2% | 0.8% | SEK 257.4m | SEK 2.84 | PS2.4x | E115.5% | n/a | Tech | ||
ORGC | SEK 3.05 | -0.3% | -15.3% | SEK 299.3m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
CRAD B | SEK 40.85 | -1.7% | 31.8% | SEK 1.4b | SEK 57.00 | PE25.6x | E33.9% | n/a | Healthcare | ||
ESGR B | SEK 27.80 | -4.8% | -51.1% | SEK 183.1m | SEK 58.00 | PS1x | E56.6% | n/a | Household | ||
CTM | SEK 7.37 | 1.1% | -61.6% | SEK 557.5m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
FLEXQ | SEK 9.98 | -7.2% | -42.6% | SEK 133.8m | SEK 25.00 | PS1.2x | E118.7% | n/a | Capital Goods | ||
KLAR | SEK 0.53 | 17.8% | -13.1% | SEK 68.8m | SEK 1.00 | PB3.3x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 15.50 | -3.1% | -34.6% | SEK 544.5m | SEK 22.00 | PS1.9x | E108.0% | n/a | Software | ||
SENZA | SEK 7.35 | -3.9% | -14.1% | SEK 216.9m | SEK 16.00 | PS3.9x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 324.20 | -4.6% | 50.0% | SEK 383.0b | SEK 354.83 | PE111x | E35.9% | 1.1% | Diversified Financials | ||
RUSTA | SEK 67.60 | -8.9% | n/a | SEK 10.2b | SEK 86.00 | PE25.1x | E22.2% | 1.7% | Retail | ||
EGTX | SEK 5.61 | -3.3% | 37.7% | SEK 1.6b | SEK 11.40 | PS23.2x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.47 | 6.8% | -46.3% | SEK 175.4m | n/a | PS1.9x | E66.8% | n/a | Software | ||
LIME | SEK 316.00 | -1.6% | 15.3% | SEK 4.2b | SEK 353.33 | PE48.8x | E24.1% | 1.1% | Software | ||
RAIL | SEK 30.60 | 3.4% | 68.6% | SEK 738.2m | SEK 34.00 | PE16.8x | E27.0% | 2.3% | Transportation |